Maynard Um
-
-
-
-
-
-
-
CalciMedica (CALC) Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxoraâ„¢ in AKI with Respiratory Failure
-
-
-
-
-
-
-
CalciMedica (CALC) PT Lowered to $16 at H.C. Wainwright
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on CalciMedica (CALC)
-
-
-
406,884 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

